Despite
the significant development of graphitic carbon nitride
(g-C3N4) as a catalytic material, the biomedical
application of this compound is rarely discussed in the existing literature.
For the first time, we report on the synthesis of citrate-capped C3N4 nanodots (C-C3N4 NDs)
and their potential application as a nanomedicine against lead poisoning.
The physicochemical properties of the nanodots have been explored
extensively using microscopic and spectroscopic tools. The generation
of a significant amount of reactive oxygen species (ROS) has been
witnessed for the as-synthesized citrate-capped nanodots. The C-C3N4 NDs can effectively bind to Pb(II), leading
to the formation of a stable, soluble complex to eliminate Pb(II)
from circulation. In addition, it has been demonstrated that the complex
can be detected using spectroscopic tools, thereby making the nanodots
potential markers for Pb(II) detection. These biocompatible NDs have
also been found to have the potential to protect cellular components
from ROS-associated damages while maintaining the cellular eustress
condition. The present study establishes the dual action of C-C3N4 NDs as a potential lead detector as well as
an alternative, nontoxic, biocompatible solution against lead toxicity.